PQQ is a redox cofactor that stimulates mitochondrial biogenesis — the creation of new mitochondria. Our research identifies this as the primary mechanism behind PQQ's biological activity, though the clinical evidence in humans is surprisingly thin. A small Japanese trial found 20mg/day improved sleep quality and reduced fatigue, and another found it reduced CRP (inflammation) by 45%. PQQ is genuinely active at the molecular level (PGC-1α activation, antioxidant cycling), but the human evidence doesn't yet match the mechanistic promise. It's expensive, and better-studied options exist for most claimed benefits.
PQQ activates the CREB → PGC-1α signaling pathway, which is the master switch for mitochondrial biogenesis — literally telling cells to build new mitochondria. More mitochondria = more cellular energy capacity. As an antioxidant, PQQ is remarkably stable — it can undergo ~20,000 redox cycles compared to ~4 for vitamin C, making it one of the most efficient catalytic antioxidants known. It also acts as a growth factor for nerve cells (NGF induction), though this is primarily demonstrated in cell culture and animal models.
No significant drug interactions have been identified in clinical literature. PQQ is a naturally occurring compound found in nanogram quantities in many foods. At supplement doses of 10-20mg, no pharmacological interactions have been documented.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.